A Look At Norton Rose Fulbright's Global Investigations Team US_36638_REPRINT: A Look At Norton Rose Fulbright's Global Investigations Team

A Look at Norton Rose Fulbright's global investigations team

Law360

United States |  Publication |  October 5, 2021

Download the Law360 reprint

Law360 reports that we have "hired aggressively this year, drawing heavyweights from competitors and feeing up the ranks of its global investigations team."

Download the full Law360 article, "A Look at Norton Rose Fulbright's Global Investigations Team."



Contacts

Tim Byrne
Tim Byrne
Partner
T: +1 212 318 3260
tim.byrne@nortonrosefulbright.com
Celia Cohen
Celia Cohen
Co-Head of Financial Institutions, United States
T: +1 212 318 3350
celia.cohen@nortonrosefulbright.com
Tom Coulter
Tom Coulter
Partner
T: +1 202 662 4765
tom.coulter@nortonrosefulbright.com
Jay Dewald
Jay Dewald
Head of Healthcare Investigations, United States
T: +1 210 270 7180
jay.dewald@nortonrosefulbright.com
Christopher Pelham
Christopher Pelham
Head of Litigation and Disputes, Los Angeles
T: +1 213 892 9221
christopher.pelham@nortonrosefulbright.com
Sandeep Savla
Sandeep Savla
Co-Head of Regulatory, Investigations, Securities and Compliance, United States
T: +1 212 318 3159
sandeep.savla@nortonrosefulbright.com
Julie Searle
Julie Searle
Partner
T: +1 512 536 3039
julie.searle@nortonrosefulbright.com
Brian A. Sun
Brian A. Sun
Partner
T: +1 213 892 9222
brian.sun@nortonrosefulbright.com

Industries:

Practice areas:

Recent publications

Answering questions raised by the No Surprises Act

Publication

What you need to know: Medicare CY 2023 PFS and OPPS and ASC final rules

The Centers for Medicare and Medicaid Services recently released public inspection copies of its annual payment final rules under the Medicare Physician Fee Schedule and the Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems for CY 2023.

United States | November 29, 2022

Healthcare
Full scope enablement in functional limitation claims

Publication

Full scope enablement in functional limitation claims

Two recent Federal Circuit decisions in the Amgen Inc. v. Sanofi patent infringement litigation seem to signal the demise of antibody genus claims, but will the Solicitor General and, ultimately the Supreme Court agree?

United States | November 28, 2022

Intellectual property
Digital concept of networks

Publication

IBOR transition

IBOR reform or LIBOR replacement represents one of the biggest changes to the financial services industry and impacts on all businesses that deal with it.

Global | November 28, 2022

IBOR and benchmark reform
site search

Subscribe and stay up to date with the latest legal news, information and events...

Register now